Dr. David Arterburn explains reassuring findings about the nation's most widely used anti-obesity drug.
Dr. Gregory Simon says research is needed to see if this new drug for persistent depression will prevent suicides.
In this short video, Dr. Sascha Dublin tells why KP is an ideal place to pursue her passion: Research to help vulnerable patients get the right drug treatment.
With $10 million from NIMH, KPWHRI is leading a multi-site study to ensure safe prescribing of antipsychotic drugs for youth with behavioral disorders.
For over a decade, Dr. Michael Von Korff and others have been working on a strategy to stop the opioid epidemic. Here’s an outline.
A GHRI researcher worries about easy access to prescription meds after seeing for herself how common they are across the border.